公司股东户数为2.35万户，前十大股东持股数量为1.02亿股，占总股本比例为50.18%，前十大股东持股 情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | J | 武汉统盛投资有限公司 | 40.92% | | 2 | 梁栋国 | 5.18% | | 3 王铁 | 姚寅之 | 1.13% 0.55% | | રે | 武汉回盛生物科技股份有限公司-2023年员工持股计划 | 0.49% | | 壬萌 6 | | 0.43% | | 7 | 平安资管-工商银行-鑫福37号资产管理产品 | 0.40% | | 8 | 中汇人寿保险股份有限公司-分红产品 | 0.40% | | 9 | UBS AG | 0.38% | | 10 | 谭绮辉 | 0.32% | 2025年8月6日，回盛生物(300871.SZ)发布2025年中报。 公司营业总收入为8.22亿元。归母净利润为1.17亿元。经营活动现金净流入为1.24亿元。 公司最新资产负债率为30.41%。 公司最新毛利率为27.56%。最新ROE为5.69%。 公司摊薄每股收益为0.66元。 公司最新总资产周转率为0 ...

Core Insights - The company, Fengli Intelligent (301368.SZ), reported a total revenue of 242 million yuan for the first half of 2025, marking an increase of 615,600 yuan compared to the same period last year, achieving a 0.25% year-on-year growth [1] - The net profit attributable to shareholders was 3.2244 million yuan, with net cash inflow from operating activities amounting to 17.8634 million yuan, an increase of 32.8381 million yuan from the previous year [1] Financial Metrics - The latest debt-to-asset ratio stands at 33.52% [3] - The gross profit margin is reported at 13.85%, reflecting an increase of 1.33 percentage points from the previous quarter [3] - The return on equity (ROE) is at 0.33% [3] - The diluted earnings per share (EPS) is 0.03 yuan [3] - The total asset turnover ratio is 0.17 times, while the inventory turnover ratio is 1.34 times [3] Shareholder Information - The number of shareholders is 26,900, with the top ten shareholders holding a total of 63.4506 million shares, accounting for 52.83% of the total share capital [3] - The largest shareholder is Zhejiang Fengli Transmission Technology Co., Ltd., holding 36.9% of the shares [3]

2025年8月5日，凯尔达(688255.SH)发布2025年中报。 公司营业总收入为3.16亿元。归母净利润为236.50万元。经营活动现金净流入为1104.28万元。 | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | T | 凯尔达集团有限公司 | 34.40% | | 2 | 安川电机(中国)有限公司 | 13.75% | | 3 | 海南珍金投资合伙企业(普通合伙) | 1.79% | | 4 | 黄兆京 | 1.48% | | 5 | 兴业银行股份有限公司-华夏中证机器人交易型开放式指数证券投资基金 | 1.36% | | 6 | 王霖 | 1.31% | | 7 | 林秀玲 | 1.11% | | 8 | 浙江东南网架集团有限公司 | 0.93% | | 9 | 平安基金-中国平安人寿保险股份有限公司-寿险传统-低-平安基金-平安人寿权益 4号MOM单一资产管理计划 | 0.82% | | 10 | 邵逸群 | 0.55% | 公司最新毛利率为17.51%。最新ROE为0.23%。 公司摊薄每股收益为0.02元。 公司最新总资产周转率为0.26次。最新存货周转率 ...

公司最新资产负债率为42.35%。 2025年8月1日，益生股份(002458.SZ)发布2025年中报。 公司营业总收入为13.21亿元。归母净利润为615.51万元。经营活动现金净流入为1.43亿元。 公司最新总资产周转率为0.18次。最新存货周转率为2.91次，较去年同期存货周转率增加0.65次，同比较去年同期上涨29.10%。 公司股东户数为4.80万户，前十大股东持股数量为6.15亿股，占总股本比例为55.63%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | l | 曹积生 | 40.8. | | 2 | 深圳毕升私募证券基金管理有限公司-必胜年年升1号私募基金 | 3.37 | | 3 | 济南泰浩投资合伙企业(有限合伙) | 3.10 | | 4 | 迟汉东 | 2.52 | | 5 | 李玲 | 1.71 | | ଚି | 柳炳兰 | 0.97 | | 7 | 耿培梁 | 0.96 | | 8 | 浙商银行股份有限公司-国泰中证畜牧养殖交易型开放式指数证券投资基金 | 0.85 | | g | 李秀国 | 0.70 | | 10 | ...

2025年7月31日，宁德时代(300750.SZ)发布2025年中报。 公司最新总资产周转率为0.22次，较去年同期总资产周转率减少0.02次，同比较去年同期下降7.09%。 最新存货周转率为2.03次，较去年同期存货周转率减少0.59次，同比较去年同期下降22.53%。 公司营业总收入为1788.86亿元。归母净利润为304.85亿元。经营活动现金净流入为586.87亿元。 公司股东户数为22.64万户，前十大股东持股数量为29.25亿股，占总股本比例为64.16%，前十大股东持 股情况如下： 公司最新资产负债率为62.59%。 公司最新毛利率为25.02%，较去年同期毛利率减少1.51个百分点。最新ROE为10.34%，较去年同期ROE 减少1.32个百分点。 公司摊薄每股收益为6.92元。 | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | J | 厦门瑞庭投资有限公司 | 22.47% | | 2 | 香港中央结算有限公司 | 13.31% | | 3 | 黄世霖 | 10.22% | | 4 | 宁波联合创新新能源投资管理合伙企业(有限合伙) | 6.23% | ...

公司摊薄每股收益为0.41元。 公司最新总资产周转率为0.36次，较去年同期总资产周转率减少0.12次，同比较去年同期下降24.81%。最新存货周转率为1.32次，较去年同期存货周转率减 少0.34次，同比较去年同期下降20.29%。 公司股东户数为3.84万户，前十大股东持股数量为1.82亿股，占总股本比例为72.46%，前十大股东持股情况如下： | 序号 | 股东名称 | 持股 | | --- | --- | --- | | 1 | 袁微微 | 39.6 | | 2 | 郭旭辉 | 30.2 | | 3 | 香港中央结算有限公司 | 0.49 | | ব | 东台智展企业管理合伙企业(有限合伙) | 0.32 | | 5 | 中国银行股份有限公司-易方达供给改革灵活配置混合型证券投资基金 | 0.32 | | 6 | 中国农业银行股份有限公司 宝盈策略增长混合型证券投资基金 | 0.30 | | 7 | 招商银行股份有限公司-南方中证1000交易型开放式指数证券投资基金 | 0.28 | | 8 | 马新成 | 0.27 | | g | 中国农业银行股份有限公司-宝盈科技30灵活配置混合型证券投资基金 | ...

2025年7月30日，辉煌科技(002296.SZ)发布2025年中报。 公司营业总收入为4.04亿元，较去年同报告期营业总收入增加7108.21万元，实现2年连续上涨，同比较 去年同期上涨21.34%。归母净利润为1.35亿元，较去年同报告期归母净利润增加2195.55万元，实现2年 连续上涨，同比较去年同期上涨19.50%。经营活动现金净流入为5526.74万元。 公司最新资产负债率为25.02%。 公司最新毛利率为57.34%。最新ROE为5.67%，较去年同期ROE增加0.38个百分点。 公司摊薄每股收益为0.35元，较去年同报告期摊薄每股收益增加0.06元，实现2年连续上涨，同比较去年 同期上涨18.95%。 公司最新总资产周转率为0.13次，较去年同期总资产周转率持平，实现2年连续上涨，同比较去年同期 上涨2.26%。最新存货周转率为0.34次，较去年同期存货周转率增加0.10次，同比较去年同期上涨 41.51%。 公司股东户数为4.18万户，前十大股东持股数量为8091.48万股，占总股本比例为20.77%，前十大股东 持股情况如下： | 序号 | 股东名称 | 持股比例 | | --- | - ...

Core Insights - Guobang Pharmaceutical (605507.SH) reported its 2025 mid-year financial results, highlighting a total revenue of 3.026 billion yuan and a net profit attributable to shareholders of 456 million yuan [2]. Financial Performance - The company's total revenue reached 3.026 billion yuan, with a net profit of 456 million yuan [2]. - Operating cash flow showed a net inflow of 103 million yuan [2]. - The latest gross profit margin was recorded at 26.85%, while the return on equity (ROE) stood at 5.65% [5]. - The diluted earnings per share were reported at 0.82 yuan [6]. Balance Sheet Metrics - The current asset-liability ratio is 25.41%, which reflects an increase of 0.52 percentage points compared to the same period last year [4]. - The total asset turnover ratio remained stable year-on-year, although it decreased by 0.88% compared to the previous year [6]. - The inventory turnover ratio was 1.55 times, showing a decrease of 0.02 times year-on-year, which is a decline of 0.97% compared to the same period last year [6]. Shareholder Structure - The number of shareholders is approximately 25,000, with the top ten shareholders holding a total of 357 million shares, accounting for 63.85% of the total share capital [6]. - The largest shareholder is Xinchang Ander Trading Co., Ltd., holding 23.08% of the shares [6].

2025年7月30日，金杯电工(002533.SZ)发布2025年中报。 公司营业总收入为93.35亿元。归母净利润为2.96亿元。经营活动现金净流入为-11.83亿元，较去年同报 告期经营活动现金净流入减少3.06亿元。 公司最新总资产周转率为0.86次，较去年同期总资产周转率减少0.03次，同比较去年同期下降3.40%。 最新存货周转率为5.15次。 公司股东户数为4.38万户，前十大股东持股数量为3.13亿股，占总股本比例为42.67%，前十大股东持股 情况如下： | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | I | 深圳市能翔投资发展有限公司 | 15.69% | | 吴字愚 2 | | 8.18% | | 3 周祖勤 | | 6.23% | | 4 | 湖南闽能投资有限公司 | 4.08% | | 范志宏 ટ | | 2.43% | | 6 | 香港中央结算有限公司 | 2.19% | | 察辉庭 7 | | 1.69% | | 8 | 中国建设银行股份有限公司-国寿安保智慧生活股票型证券投资基金 | 0.76% | | 9 花伟 | | 0.75% | | ...

Core Viewpoint - Xi'an Ruilian New Materials Co., Ltd. received an inquiry letter from the Shanghai Stock Exchange regarding its 2024 annual report, prompting the company to provide detailed responses about its financial performance and customer relationships [1]. Financial Performance - The company's total revenue for 2024 reached 145.87 million yuan, representing a year-on-year increase of 13.70%, with domestic sales accounting for 54.44 million yuan [2][3]. - The gross profit margins for overseas and domestic sales were 49.10% and 35.95%, respectively, both showing year-on-year increases [2][3]. Customer Analysis - The top five domestic customers contributed significantly to the revenue, with a total of 45.00 million yuan in sales, marking a 44.83% increase from the previous year [2]. - The overseas sales revenue saw a substantial increase, attributed to the recovery in the display materials market and rising downstream demand [3][4]. Industry Trends - The display industry is experiencing a rebound, with a projected global display panel shipment area of approximately 263 million square meters in 2024, a 6% year-on-year increase, and a market size of about 133.8 billion USD, up 13% [4][5]. - The pharmaceutical CDMO industry is expanding rapidly, driven by increasing healthcare demands and an aging population, with expectations for China's CDMO market share to grow significantly by 2025 [6]. Product and Cost Analysis - The company reported a significant increase in gross profit margins due to improved product mix and cost reductions, particularly in the display materials segment, which saw a gross margin increase of 9.02 percentage points [8][11]. - The unit cost of display materials decreased by 7.97%, contributing to the overall improvement in gross margins [10][12]. Investment and Partnership Developments - The company is involved in a joint venture with the Japanese company Idemitsu, focusing on OLED materials, with significant progress reported in customer transfers and patent licensing [15][16]. - The financial performance of the joint venture, Idemitsu Electronic Materials (China), showed a substantial increase in revenue and net profit in the first quarter of 2025 compared to the previous year [17].